A key facet of Bayer’s social responsibility is the way it conducts its business. This is why we adhere to international guidelines and were a founding member of the United Nations Global Compact voluntary initiative in the spheres of human rights, labor standards, environmental protection and anti-corruption. What’s more, Bayer has adopted internal regulations with ethical standards that in many cases go beyond the legal requirements.
Integrity is one of our four corporate values – alongside leadership, flexibility and efficiency – and thus a guideline for all our activities. We have also set down the way that we work in a Corporate Compliance Policy that is mandatory for all employees. Special rules for lobbying and marketing are in place to, among other things, ensure the transparency of our actions.
Bayer collaborates with doctors and other medical specialists in a variety of ways, for example in clinical trials. The expertise and time that doctors invest on our behalf are appropriately recompensed. Bayer also engages in essential further medical education in the form of specialist conferences and training. In order to ensure transparency in this regard, too, we voluntarily publish our payments to doctors, other healthcare professionals and healthcare organizations each year. This includes all direct and indirect, monetary and non-monetary payments relating to the development and marketing of prescription medicines.
This commitment to transparency applies both to Bayer and to its collaborations with patients’ organizations, whose independence we respect above all and whose assistance we explicitly acknowledge.